Search

everythinglearnresearchcommunity

for

Search:↓

The new drug carriers show promise for better targeting and treating ovarian cancer.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Different parts of the body have unique immune characteristics in their skin.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Some skin tumors may start from hair follicle stem cells.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Scientists made a mouse that shows how a specific protein in the skin changes and affects hair growth and shape.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.